A preliminary study presented at the American Heart Association’s Basic Cardiovascular Sciences Scientific Sessions 2026 in Boston reveals a potential biological link between gum disease bacteria and a common, serious heart valve condition known as calcific aortic valve stenosis (CAVS). The research, conducted by scientists at the State Key Laboratory of Cardiovascular Disease of Fuwai Hospital in Beijing, focused on Porphyromonas gingivalis (P. gingivalis), a bacterium that plays a major role in gum inflammation and tissue destruction. The findings indicate that this oral pathogen may directly contribute to the thickening and calcification of the aortic valve, which restricts blood flow from the heart and can lead to fatigue, chest pain, heart failure, and premature death.
Currently, no medications exist to prevent or slow CAVS progression; the standard treatment for severe cases is valve replacement surgery. The study’s co-lead author, Chenyang Li, M.D., a Ph.D. candidate at Fuwai Hospital, emphasized the importance of the discovery: “We hope our findings demonstrating the link between periodontal disease and CAVS will stimulate further research into new preventive and therapeutic approaches for this condition.” The researchers measured bacterial levels in human cardiac valve tissue removed during valve replacement surgery and found a notably higher presence of P. gingivalis in calcified valves compared to non-calcified ones.
In mouse experiments, repeated exposure to live P. gingivalis led to bacterial accumulation in aortic valves, increased calcification, and symptoms of aortic stenosis. Preventive antibiotic treatment reduced these effects. Further investigation revealed that P. gingivalis activated interleukin-1 beta (IL-1β), an inflammation-spurring protein. When researchers genetically deleted IL-1β in mice, calcification and valve symptoms were significantly reduced even in the presence of the bacteria.
“The key message is simple: take good care of your oral health,” Li said. “Good oral hygiene and treatment of periodontal disease are important for overall health and may also have benefits for cardiovascular health.” Eduardo Sanchez, M.D., M.P.H., FAHA, chief medical officer for prevention for the American Heart Association, added, “This study adds to the growing evidence that oral health and heart health are closely connected.” The American Heart Association’s Healthy Smiles, Healthy Hearts™ initiative provides dental care teams with professional education and resources to bridge oral and cardiovascular health.
While the findings are preliminary and not yet peer-reviewed, they underscore the importance of periodontal health in potentially preventing the most common form of heart valve disease. The researchers have initiated a clinical study to further evaluate the link between gum disease and CAVS. For business and technology leaders, this study highlights the growing intersection of oral health and systemic disease, suggesting that innovations in dental care and inflammation-targeting therapies could have significant implications for cardiovascular disease management and healthcare costs.
